Verastem Oncology Announces Late-Breaking Oral Presentation of RAMP 201 Low-Grade Serous Ovarian Cancer Molecular Profiling and Tumor Biomarker Analysis at IGCS 2026 Annual Global Meeting

Go back to Verastem Oncology Announces Late-Breaking Oral Presentation of RAMP 201 Low-Grade Serous Ovarian Cancer Molecular Profiling and Tumor Biomarker Analysis at IGCS 2026 Annual Global Meeting
VERASTEM SHS (NASDAQ: VSTM) Delayed: 10.06 +0.85 (9.23%)
Previous Close $9.21    52 Week High $2.43 
Open $9.20    52 Week Low $1.05 
Day High $10.11    P/E N/A 
Day Low $9.14    EPS $-1.79 
Volume 5,947,213